Integrating Accompanying Patients into Clinical Oncology Teams: Limiting and Facilitating Factors
Authors: Pomey Marie-Pascale , Paquette Jesseca , Nelea Monica Iliescu , Vialaron Cécile , Mourad Rim , Bouchard Karine , Normandin Louise , Côté Marie-Andrée , Desforges Mado , Pomey-Carpentier Pénélope , Fortin Israël , Ganache Isabelle , Régis Catherine , Rosberger Zeev , Charpentier Danielle , Vachon Marie-France , Bélanger Lynda , Dorval Michel , Ghadiri Djahanchah P. , Lavoie-Tremblay Mélanie , Boivin Antoine , Pelletier Jean-François , Fernandez Nicolas , Danino Alain M. , de Guise Michèle 
Published: May 2023

Abstract
Objectives
Since 2018, four establishments in Quebec have been instrumental in implementing the PAROLE-Onco program, which introduced accompanying patients (APs) in healthcare teams to improve cancer patients’ experience. APs are patient advisors who have acquired specific experiential knowledge related to living with cancer, using services, and interacting with healthcare professionals. They are therefore in a unique and reliable position to be able to provide emotional, informational, cognitive and navigational support to patients dealing with cancer. We aimed to explore APs’ perspectives regarding the limiting and facilitating factors in terms of how they are integrated into the clinical oncology teams.
Methods
A qualitative study based on semi-structured interviews and focus groups was conducted with 20 APs at the beginning of their intervention (T1) and two years afterwards (T2). Limiting and facilitating factors of APs’ integration into clinical teams were analyzed in terms of governance, culture, resources and tools.
Results
The most significant limiting factors raised by APs to be integrated into clinical teams were: governance involvement, organizational boundaries, team members' availabilities, and confusion about the specific roles played by APs. Communication challenges were also raised, leading to inadequate promotion of the program to patients. The lack of time, space and compensation were also mentioned as limiting factors. Creating opportunities for team members to meet APs, building trust and teaching team members how APs’ activities are complementary to theirs were enhancing factors. Other facilitators include APs being involved in decision-making committees, being leaders in the PAROLE-Onco program promotion to patients and clinical team members and creating opportunities to communicate with team members to help enhance their work and provide feedback to improve patient services. Awareness of APs’ added value for the team and patients is also a key facilitator. Regarding tools, offering accompanying services by telephone allows both patients and APs to benefit from the flexibility they need.
Conclusion
Over time, APs were able to identify the best factors for successful implementation. Recommendations include APs and professionals working in co-construction on organization, leadership, resources, and status factors. This could help catalyze a change in culture within health establishments and allow people dealing with cancer to benefit from the experiential knowledge of other patients within their clinical team.